51.89

3.28% -1.8101

Twist Bioscience Corp (TWST)

Overview News Price History Option Chain Financials Discussions Forecast

Twist Bioscience Corp stock is traded at $51.89, with a volume of 473.17K. It is down -3.28% in the last 24 hours and up +13.85% over the past month. Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Previous Close:

$53.70

Open:

$53.71

24h Volume:

473.17K

Relative Volume:

0.58

Market Cap:

$3.20B

Revenue:

$277.49M

Net Income/Loss:

$-192.14M

P/E Ratio:

-15.44

EPS:

-3.36

Net Cash Flow:

$-95.52M

1W Performance:

-0.82%

1M Performance:

+13.85%

6M Performance:

+16.58%

1Y Performance:

+48.52%

1-Day Range:

$51.09

$54.26

1-Week Range:

$45.30

$54.74

52-Week Range:

$27.41

$60.90

Twist Bioscience Corp Stock (TWST) Company Profile

Name

Twist Bioscience Corp

Sector

Healthcare (1187)

Industry

Diagnostics & Research (60)

Phone

800-719-0671

Address

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA

Employee

923

Twitter

@TwistBioscience

Next Earnings Date

2025-02-03

Latest SEC Filings

TWST's Discussions on Twitter

Compare TWST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TWST Twist Bioscience Corp	51.86	3.20B	277.49M	-192.14M	-95.52M	-3.36
TMO Thermo Fisher Scientific Inc	572.61	219.06B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	207.67	151.02B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	145.90	42.12B	6.51B	1.29B	1.37B	4.42
IDXX Idexx Laboratories Inc	459.15	37.71B	3.84B	866.24M	792.60M	10.37
IQV Iqvia Holdings Inc	208.23	36.97B	15.32B	1.41B	1.96B	7.62

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-13-24	Initiated	Wolfe Research	Outperform
Jun-04-24	Initiated	Guggenheim	Buy
Jan-17-24	Upgrade	Goldman	Neutral → Buy
Sep-27-23	Initiated	Berenberg	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral
Apr-12-21	Initiated	Piper Sandler	Overweight
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral

View All

Twist Bioscience Corp Stock (TWST) Latest News

Feb 06, 2025

Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) Insider Sells 806 Shares of Stock - MarketBeat

Feb 06, 2025

Twist Bioscience (NASDAQ:TWST) Price Target Raised to $62.00 at Scotiabank - MarketBeat

Feb 06, 2025

Twist Bioscience Co. (NASDAQ:TWST) CEO Sells $256,620.00 in Stock - MarketBeat

Feb 06, 2025

Twist Bioscience Co. (NASDAQ:TWST) COO Sells $140,400.75 in Stock - MarketBeat

Feb 06, 2025

Twist Bioscience Corporation (TWST): Among Cathie Wood’s Top Stock Picks for 2025 - Insider Monkey

Feb 06, 2025

Twist Bioscience's chief accounting officer sells shares worth $9,130 - MSN

Feb 06, 2025

Twist Bioscience president Finn sells $140,406 in stock - MSN

Feb 06, 2025

Twist Bioscience (TWST) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Feb 06, 2025

Twist Bioscience CEO Emily Leproust sells $256,630 in company stock By Investing.com - Investing.com Australia

Feb 06, 2025

Feb 05, 2025

Twist Bioscience SVP sells $62,134 in common stock By Investing.com - Investing.com Canada

Feb 05, 2025

Twist Bioscience SVP sells $62,134 in common stock - MSN

Feb 05, 2025

Twist Bioscience CEO Emily Leproust sells $256,630 in company stock - MSN

Feb 05, 2025

Twist Bioscience president Finn sells $140,406 in stock By Investing.com - Investing.com Nigeria

Feb 05, 2025

Twist Bioscience exec sells stock worth $39,777 By Investing.com - Investing.com Nigeria

Feb 05, 2025

Twist Bioscience's chief accounting officer sells shares worth $9,130 By Investing.com - Investing.com South Africa

Feb 05, 2025

Twist Bioscience exec sells stock worth $39,777 - Investing.com India

Feb 05, 2025

Twist Bioscience (NASDAQ:TWST) Stock Price Down 3.7%Here's What Happened - MarketBeat

Feb 05, 2025

Brokers Offer Predictions for TWST Q2 Earnings - MarketBeat

Feb 05, 2025

Jennison Associates LLC Grows Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat

Feb 05, 2025

Feb 04, 2025

Twist Bioscience (NASDAQ:TWST) Price Target Raised to $40.00 at JPMorgan Chase & Co. - MarketBeat

Feb 04, 2025

Twist Bioscience's SWOT analysis: stock outlook amid operational gains By Investing.com - Investing.com South Africa

Feb 04, 2025

Forecasting The Future: 6 Analyst Projections For Twist Bioscience - Benzinga

Feb 04, 2025

Twist Bioscience (NASDAQ:TWST) Stock Price Expected to Rise, Robert W. Baird Analyst Says - MarketBeat

Feb 04, 2025

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2025 Earnings Call Transcript - Insider Monkey

Feb 04, 2025

Scotiabank lifts Twist Bioscience target to $62, keeps top rating - Investing.com

Feb 04, 2025

Twist Bioscience's SWOT analysis: stock outlook amid operational gains - Investing.com

Feb 04, 2025